Health Care & Life Sciences » Pharmaceuticals | Cathay International Holdings Ltd.

Cathay International Holdings Ltd. | Ownership

Companies that own Cathay International Holdings Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Lombard Odier Asset Management (Europe) Ltd.
46,593,211
12.53%
0
0.07%
04/01/2017
AlphaGen Capital Ltd.
26,052,503
7.01%
533,333
2.84%
03/22/2017
Henderson Global Investors Ltd.
20,540,708
5.52%
1,451,667
0%
03/22/2017
Northern Trust Global Investments Ltd. (Securities Lending)
12,675,000
3.41%
0
0.02%
07/02/2018
Legal & General Investment Management Ltd.
3,623,000
0.97%
-25,000
0%
07/02/2018
Hargreaves Lansdown Stockbrokers Ltd.
1,054,000
0.28%
147,000
0%
07/02/2018
Winterflood Securities Ltd. (Market-Maker)
762,000
0.21%
-106,000
0.35%
07/02/2018
Walker Crips Stockbrokers Ltd.
550,000
0.15%
0
0%
07/02/2018
HSBC Bank Plc (Market-Maker)
195,000
0.05%
0
0%
07/02/2018
HSBC Global Asset Management (UK) Ltd.
134,000
0.04%
-24,000
0%
07/02/2018

About Cathay International Holdings

View Profile
Address
Suites 1203-4, 12/F
Hong Kong
Hong Kong
Employees -
Website http://www.cathay-intl.com.hk
Updated 07/08/2019
Cathay International Holdings Ltd. engages in investment activities with interests in the healthcare business and hotel operations. It operates through the following segments: Lansen, Haizi, Natural Dailyhealth, Botai, and Hotel. The Lansen segment focuses on the manufacture, marketing, and sale of specialty pharmaceuticals, plant extracts, healthcare products, and other pharmaceuticals in China.